Franklin Genomic Advancements ETF
$35.45
USD
Last updated on --.
24h volume19.00
24h highest35.4513 USD
24h lowest35.4513 USD
24h Price movement-0.71%


HELX recent prices
24 Hours
-0.71%-$0.254
30 days
+5.64%+$1.905
60 days
+6.60%+$2.210
90 days
+9.33%+$2.984
Key data
Previous close35.7049 USD
Market cap--
Volume19.00
P/E ratio--
Dividend yield (TTM)--
Dividend amount0.14334 USD
Next ex-dividend dateDec 30, 2025
Next payment dateJan 8, 2026
EPS diluted (TTM)--
Net income (FY)57.70M USD
Revenue (FY)751.91M USD
Last report dateFeb 24, 2022
HELX conversion tables
| 0.5 HELX | 17.72 USD |
| 1 HELX | 35.45 USD |
| 5 HELX | 177.25 USD |
| 10 HELX | 354.51 USD |
| 0.5 USD | 0.014104 HELX |
| 1 USD | 0.028208 HELX |
| 5 USD | 0.14104 HELX |
| 10 USD | 0.28208 HELX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
HELX is trading at $35.45, -0.71% over the last 24 hours. Track live moves on the price chart at the top of this page.
The HELX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. HELX is currently trading at $35.45, -0.71% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on HELX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. HELX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from HELX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against HELX's historical range and other companies in the sector.
Franklin Genomic Advancements ETF's market cap is currently --. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume19.00
24h highest35.4513 USD
24h lowest35.4513 USD
24h Price movement-0.71%


Start trade with HELX Perpetual
Sign up to trade














